Press releases
- Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
- Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders
- Gabather reports initial positive results from the EEG/fMRI target engagement study
Key statistics
On Tuesday, Gabather AB (GABA:STO) closed at 2.00, 151.89% above the 52 week low of 0.792 set on Feb 29, 2024.
52-week range
Open | 1.98 |
---|---|
High | 2.05 |
Low | 1.70 |
Bid | 1.66 |
Offer | 2.00 |
Previous close | 1.98 |
Average volume | 19.94k |
---|---|
Shares outstanding | 18.10m |
Free float | 17.30m |
P/E (TTM) | -- |
Market cap | 35.83m SEK |
EPS (TTM) | -0.652 SEK |
Data delayed at least 15 minutes, as of Apr 30 2024 12:30 BST.
More ▼